Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-24-000057
Filing Date
2024-11-08
Accepted
2024-11-08 08:18:17
Documents
92
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20240930.htm   iXBRL 10-Q 1139460
2 EX-31.1 exhibit311-certificationof.htm EX-31.1 10441
3 EX-31.2 exhibit312-certificationof.htm EX-31.2 10439
4 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6100
  Complete submission text file 0000899923-24-000057.txt   6973540

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20240930.xsd EX-101.SCH 53399
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20240930_cal.xml EX-101.CAL 74682
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20240930_def.xml EX-101.DEF 215688
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20240930_lab.xml EX-101.LAB 678454
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20240930_pre.xml EX-101.PRE 458319
95 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20240930_htm.xml XML 947399
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 241438078
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)